Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa

Abstract Tuberculosis (TB) remains a leading infectious disease killer globally. Treatment outcomes are especially poor among people with extensively drug-resistant (XDR) TB, until recently defined as rifampicin-resistant (RR) TB with resistance to an aminoglycoside (amikacin) and a fluoroquinolone...

Full description

Bibliographic Details
Main Authors: Karla Therese L. Sy, Sarah V. Leavitt, Margaretha de Vos, Tania Dolby, Jacob Bor, C. Robert Horsburgh, Robin M. Warren, Elizabeth M. Streicher, Helen E. Jenkins, Karen R. Jacobson
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-14581-4